https://www.selleckchem.com/pr....oducts/pf-04691502.h
The detection of lymph-node metastases (N1) with conventional imaging such as magnetic resonance imaging (MRI) and computed tomography (CT) is inadequate for primarily diagnosed prostate cancer (PCa). Prostate-specific membrane antigen (PSMA) PET/CT is successfully introduced for the staging of (biochemically) recurrent PCa. Besides the frequently used gallium-labelled PSMA tracers, fluorine-labelled PSMA tracers are available. This study examined the diagnostic accuracy of F-DCFPyL (PSMA) PET/CT for lymph-node staging in primary PC
Like
Comment
Share
